DEMANT 📈 Demant - Overview
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060738599
DEMANT: Hearing Aids, Diagnostic Products, Headsets, Gaming Solutions
Demand for innovative hearing solutions and audio technology has driven the growth of Demant A/S, a company that has been at the forefront of these industries for over a century. With operations spanning Europe, North America, the Asia Pacific, and other international markets, Demant A/S has established itself as a leading player in the hearing healthcare and audio technology sectors. The company's business is divided into two primary segments: Hearing Healthcare and Communications, each catering to distinct markets and customer needs.
The Hearing Healthcare segment is a critical component of Demant A/S's business, focusing on the development, manufacturing, and distribution of hearing aids, as well as diagnostic products and services designed to improve hearing and quality of life for individuals with hearing impairments. This segment leverages cutting-edge technology to create sophisticated hearing solutions that are both effective and user-friendly, addressing a wide range of hearing needs and preferences. By investing in research and development, Demant A/S continues to push the boundaries of what is possible in hearing healthcare, offering products and services that make a tangible difference in people's lives.
In contrast, the Communications segment operates under the EPOS brand, specializing in the design and production of high-quality headsets and audio solutions tailored for professional call centers, office environments, and the gaming community. EPOS products are engineered to deliver exceptional sound quality, durability, and comfort, meeting the demanding requirements of these markets. By targeting specific niches within the communications sector, Demant A/S's Communications segment has carved out a niche for itself, providing specialized solutions that enhance productivity, collaboration, and entertainment experiences.
Originally founded in 1904, Demant A/S has a rich history that reflects its commitment to innovation and customer satisfaction. The company underwent a significant transformation in March 2019, changing its name from William Demant Holding A/S to Demant A/S, a move that signaled a new chapter in its evolution. Headquartered in Smørum, Denmark, Demant A/S is listed with the ISIN code DK0060738599 and is classified as a common stock under the GICS Sub Industry of Health Care Equipment. For more information about Demant A/S and its diverse portfolio of products and services, visitors can explore the company's website at https://www.demant.com.
Additional Sources for DEMANT Stock
DEMANT Stock Overview
Market Cap in USD | 8,412m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
DEMANT Stock Ratings
Growth 5y | 8.94% |
Fundamental | 62.0% |
Dividend | 4.29% |
Rel. Strength Industry | -680 |
Analysts | - |
Fair Price Momentum | 233.03 DKK |
Fair Price DCF | 425.93 DKK |
DEMANT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 14.3% |
DEMANT Growth Ratios
Growth Correlation 3m | 32.7% |
Growth Correlation 12m | -75% |
Growth Correlation 5y | 37.9% |
CAGR 5y | 4.54% |
CAGR/Mean DD 5y | 0.20 |
Sharpe Ratio 12m | -0.35 |
Alpha | -35.84 |
Beta | 0.98 |
Volatility | 29.86% |
Current Volume | 283.7k |
Average Volume 20d | 296.9k |
As of December 21, 2024, the stock is trading at DKK 263.40 with a total of 283,732 shares traded.
Over the past week, the price has changed by -3.86%, over one month by -2.27%, over three months by -7.64% and over the past year by -13.53%.
Yes, based on ValueRay Fundamental Analyses, Demant (CO:DEMANT) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 61.96 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DEMANT as of December 2024 is 233.03. This means that DEMANT is currently overvalued and has a potential downside of -11.53%.
Demant has no consensus analysts rating.
According to ValueRays Forecast Model, DEMANT Demant will be worth about 256.9 in December 2025. The stock is currently trading at 263.40. This means that the stock has a potential downside of -2.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 296.4 | 12.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 256.9 | -2.5% |